Parameters of thromboelastography in PRP from patients with hemophilia
| . | Patients with severe hemophilia (n = 5) . | ||
|---|---|---|---|
| PRP alone . | PRP + irrelevant IgG . | PRP + anti-PN-1 . | |
| Clotting time, s | 90.20 ± 12.81 | 90.80 ± 7.64 | 88.70 ± 7.13 |
| MCF, mm | 25.25 ± 11.52 | 23.17 ± 7.42 | 30.00 ± 9.93* |
| LOT, s | 222.80 ± 50.41 | 223.60 ± 30.62 | 295.70 ± 64.69* |
| Lysis time, s | 358.40 ± 91.40 | 387.20 ± 102.10 | 480.10 ± 134.10 |
| Maximum clot elasticity | 30.20 ± 16.39 | 26.90 ± 7.89 | 38.90 ± 15.52* |
| . | Patients with severe hemophilia (n = 5) . | ||
|---|---|---|---|
| PRP alone . | PRP + irrelevant IgG . | PRP + anti-PN-1 . | |
| Clotting time, s | 90.20 ± 12.81 | 90.80 ± 7.64 | 88.70 ± 7.13 |
| MCF, mm | 25.25 ± 11.52 | 23.17 ± 7.42 | 30.00 ± 9.93* |
| LOT, s | 222.80 ± 50.41 | 223.60 ± 30.62 | 295.70 ± 64.69* |
| Lysis time, s | 358.40 ± 91.40 | 387.20 ± 102.10 | 480.10 ± 134.10 |
| Maximum clot elasticity | 30.20 ± 16.39 | 26.90 ± 7.89 | 38.90 ± 15.52* |
Means ± SD. A nonparametric 1-way ANOVA test, followed by a multiple comparison test, was used.
P < .05 vs PRP + irrelevant IgG.